BioLife Solutions, Inc (BLFS)

Etorro trading 970x250
BioLife Solutions, Inc (BLFS) Logo

About BioLife Solutions, Inc

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools for the cell and gene therapy industry in North America, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; and liquid nitrogen laboratory freezers, cryogenic equipment, and accessories. The company markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington. Address: 3303 Monte Villa Parkway, Bothell, WA, United States, 98021

BioLife Solutions, Inc News and around…

Latest news about BioLife Solutions, Inc (BLFS) common stock and company :

Peek Under The Hood: RWJ Has 12% Upside
23 Nov, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco S&P SmallCap 600 Revenue ETF (RWJ), we found that the implied analyst target price for the ETF based upon its underlying holdings is $143.14 per unit.

COO Of Biolife Solutions Makes $1.1M Sale
19 Nov, 2021 Yahoo! Finance

De De, COO at Biolife Solutions (NASDAQ:BLFS), made a large insider sell on November 18, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that De sold 21,000 shares of Biolife Solutions at prices ranging from $50.75 to $51.39. The total transaction amounted to $1,072,540. Following the transaction, De still owns 103,333 shares of Biolife Solutions worth $5,390,882.00. Biolife Solutions shares are trading up 0.33% at

Notable Biolife Solutions Insider Trades $1.0M In Company Stock
18 Nov, 2021 Yahoo! Finance

Aby J Mathew, Insider at Biolife Solutions (NASDAQ:BLFS), made a large buy and sell of company shares on November 17, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Aby J Mathew exercised options to purchase 20,000 Biolife Solutions shares at a price of $1.64 per share for a total of $32,800 on November 17. They then sold their shares on multiple transactions in the open market. They sold at prices ranging from $48.11 to

BioLife Solutions Ranks 353 Among Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500™
17 Nov, 2021 Yahoo! Finance

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced it has ranked 353 in the 27th annual Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America. BioLife Solutions annual revenue grew 336% from 2017 to 2020, driven by organic growth and

BioLife Solutions Named to Inc. Magazine Inaugural List of Best-Led Companies
15 Nov, 2021 Yahoo! Finance

BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies and the broader biopharma markets, today announced that it was named to Inc. Magazine's inaugural list of the 250 best-led companies in the United States.

BioLife Solutions Inc (BLFS) Q3 2021 Earnings Call Transcript
12 Nov, 2021 FinancialContent

BLFS earnings call for the period ending September 30, 2021.

BioLife Solutions Announces Third Quarter 2021 Financial Results
11 Nov, 2021 Yahoo! Finance

BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced financial results for the three and nine months ended September 30, 2021.

The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
11 Nov, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus MerckCommences ...

Earnings Scheduled For November 11, 2021
11 Nov, 2021 FinancialContent

Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on ...

Notable Biolife Solutions Insider Trades $1.3M In Company Stock
05 Nov, 2021 Yahoo! Finance

Michael Rice, CEO at Biolife Solutions (NASDAQ:BLFS), made a large buy and sell of company shares on November 4, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Michael Rice exercised options to purchase 22,922 Biolife Solutions shares at a price of $1.64 per share for a total of $37,592 on November 4. They then sold their shares on succeeding transactions in the open market. They sold at prices ranging from $54.72 to $56

BioLife Solutions Announces Executive Management Changes
04 Nov, 2021 Yahoo! Finance

BioLife Solutions, Inc. (the "Company") (Nasdaq: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced changes to its executive management team, effective immediately.

BioLife Solutions to Report Third Quarter 2021 Financial Results and Provide Business Update on November 11, 2021
04 Nov, 2021 Yahoo! Finance

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's third quarter 2021 financial results will be released after market close on Thursday, November 11th. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and a general business up

What Is The Ownership Structure Like For BioLife Solutions, Inc. (NASDAQ:BLFS)?
04 Nov, 2021 Yahoo! Finance

A look at the shareholders of BioLife Solutions, Inc. ( NASDAQ:BLFS ) can tell us which group is most powerful...

Analysts Estimate BioLife Solutions, Inc. (BLFS) to Report a Decline in Earnings: What to Look Out for
28 Oct, 2021 Yahoo! Finance

BioLife Solutions, Inc. (BLFS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Biolife Solutions Supports Biostorage Best Practices Through SciSafe's "Centers of Excellence" With New World-Class Facility in Amsterdam
26 Oct, 2021 Yahoo! Finance

Biolife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for cell and gene therapies ("CGT"), and its biological material storage brand SciSafe, a multi-facility provider of storage services to the CGT and broader biopharma market, today announced the opening of a new 40,000 square-foot biorepository Center of Excellence in Amsterdam, adjacent to the Schiphol Airport.

Analysts Forecast 20% Upside For XHE
22 Oct, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR— S&P— Health Care Equipment ETF (XHE), we found that the implied analyst target price for the ETF based upon its underlying holdings is $151.10 per unit.

Notable Biolife Solutions Insider Trades $860K In Company Stock
21 Oct, 2021 Yahoo! Finance

Aby Mathew, EVP And Chief Scientific Officer at Biolife Solutions (NASDAQ:BLFS), made a large buy and sell of company shares on October 20, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Aby Mathew exercised options to purchase 20,000 Biolife Solutions shares at a price of $1.64 per share for a total of $32,800 on October 20. They then sold their shares on succeeding transactions in the open market. They sold at prices r

Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom
15 Oct, 2021 FinancialContent

This company is preserving biological material and can help your portfolio grow.

Biolife Solutions Insider Trades $130K In Company Stock
13 Oct, 2021 Yahoo! Finance

Joseph C Schick, Director at Biolife Solutions (NASDAQ:BLFS), made a large insider sell on October 7, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Schick sold 3,250 shares of Biolife Solutions at prices ranging from $39.96 to $40.28. The total transaction amounted to $130,145. Following the transaction, Schick still owns 8,625 shares of the company, worth $335,253. Biolife Solutions shares are trading up 1.

CEO Of Biolife Solutions Trades $970K In Company Stock
08 Oct, 2021 Yahoo! Finance

Michael Rice, CEO at Biolife Solutions (NASDAQ:BLFS), made a large buy and sell of company shares on October 7, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Michael Rice exercised options to purchase 22,922 Biolife Solutions shares at a price of $1.64 per share for a total of $37,592 on October 7. They then sold their shares on succeeding transactions in the open market. They sold at prices ranging from $40.55 to $40.6

BioLife Solutions Leverages Expanded Bioproduction Tools and Services Portfolio in Multipoint Engagement with Leading CAR T-Cell Developer
04 Oct, 2021 Yahoo! Finance

BioLife Solutions, Inc. (NASDAQ: BLFS) a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced a broad engagement with a leading cell therapy developer, wherein BioLife's CryoStor freeze media, evo cold chain management platform and SciSafe storage services with Stirling UltraCold freezers are all being utilized by this top 10 largest global pharmaceutical company to support the anticipat

Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock
30 Sep, 2021 Yahoo! Finance

Karen A Foster, Chief Quality Officer at Biolife Solutions (NASDAQ:BLFS), made a large buy and sell of company shares on September 27, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Karen A Foster exercised options to purchase 16,332 Biolife Solutions shares at a price of $1.64 per share for a total of $26,784 on September 27. They then sold their shares on the same day in the open market. They sold at a price of $44.66

Looking Into BioLife Solutions's Return On Capital Employed
29 Sep, 2021 FinancialContent

BioLife Solutions (NASDAQ:BLFS) brought in sales totaling $31.20 million during Q2 according to data provided by Benzinga Pro. However, ...

Notable Biolife Solutions Insider Trades $971 Thousand In Company Stock
23 Sep, 2021 FinancialContent

Aby Mathew, Exec VP And Chief Scientific Off at Biolife Solutions (NASDAQ:BLFS), made a large buy and sell of company shares on ...

Interesting BLFS Put And Call Options For November 19th
20 Sep, 2021 FinancialContent

Investors in Biolife Solutions Inc (BLFS) saw new options begin trading this week, for the November 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BLFS options chain for the new November 19th contracts and identified one put and one call contract of particular interest.

BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors
20 Sep, 2021 Yahoo! Finance

BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that Joydeep Goswami, Chief Strategy and Corporate Development Officer at Illumina, will join its board of directors on October 1, 2021. In his role, he is responsible for driving planning, strategic partnerships, and acquisitions. Mr. Goswami replaces Andrew Hinson

BioLife Solutions Announces CFO Retirement
15 Sep, 2021 Yahoo! Finance

BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that Roderick de Greef, Chief Financial Officer, plans to retire on December 31, 2021 after a distinguished career with the Company. The Company has retained executive search firm Strawn Arnold to identify candidates to succeed Mr. de Greef. Mr. de Greef will consul

Why Shares in BioLife Solutions Jumped 24.4% in August
07 Sep, 2021 FinancialContent

The company, which specializes in cold-storage solutions for biotechs, had a hot month.

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
02 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
01 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

BioLife Solutions, Inc (BLFS) is a NASDAQ Common Stock listed in , ,

970x250